|
44
|
177
|
4oieA |
West nile virus non-structural protein ns1 |
|
88
|
377
|
4o6dB |
West nile virus non-structural protein 1 (ns1) form 1 crystal |
|
142
|
461
|
4nlvA |
Poliovirus polymerase - g289a/c290f loop mutant |
|
140
|
461
|
4nlyA |
Poliovirus polymerase - c290e loop mutant |
|
166
|
505
|
4nldA |
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase complex with bms-791325 also known as (1ar,12bs)-8-cyclohexyl-n-(dimethylsulfamoyl)-11-methoxy-1a-{[(1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl]carbonyl}-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide and 2-(4-fluorophenyl)-n-methyl-6-[(me |
|
28
|
203
|
4mwfC |
Structure of hepatitis c virus envelope glycoprotein e2 core bound to broadly neutralizing antibody ar3c |
|
3
|
11
|
4n0yA |
Structure of the hepatitis c envelope glycoprotein e1 antigenic region 314-324 bound to the cross-neutralizing antibody igh526 |
|
202
|
562
|
4mibA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with compound 48 (n-({(3s)-1-[6-tert-butyl-5-methoxy-8-(2-oxo-1,2-dihydropyridin-3-yl)quinolin-3-yl]pyrrolidin-3-yl}methyl)methanesulfonamide) |
|
54
|
226
|
4m9tA |
Ns2b-ns3 protease from dengue virus in the presence of dtnb, a covalent allosteric inhibitor |
|
201
|
562
|
4mk9A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 12 (n-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide) |
|
39
|
142
|
4mg3A |
Crystal structural analysis of 2a protease from coxsackievirus a16 |
|
44
|
233
|
4m9mA |
Ns2b-ns3 protease from dengue virus at ph 8.5 |
|
204
|
562
|
4mkaA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 13 (n-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide) |
|
47
|
233
|
4m9kA |
Ns2b-ns3 protease from dengue virus at ph 5.5 |
|
203
|
562
|
4mk7A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 2 (3-(3-tert-butyl-4-methoxyphenyl)pyridin-2(1h)-one) |
|
46
|
233
|
4m9iA |
A125c ns2b-ns3 protease from dengue virus at ph 5.5 |
|
334
|
891
|
4k6mA |
Crystal structure of the full-length japanese encephalitis virus ns5 |
|
206
|
562
|
4mkbA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 14 (n-(4-{(e)-2-[3-tert-butyl-2-methoxy-5-(3-oxo-2,3-dihydropyridazin-4-yl)phenyl]ethenyl}phenyl)methanesulfonamide) |
|
195
|
562
|
4miaA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with rg7109 (n-{4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-2,5-dihydropyridin-3-yl)quinolin-3-yl]phenyl}methanesulfonamide) |
|
44
|
233
|
4m9fA |
Dengue virus ns2b-ns3 protease a125c variant at ph 8.5 |
|
198
|
563
|
4jy0A |
Crystal structure of hcv ns5b polymerase in complex with compound 3 |
|
202
|
563
|
4kb7A |
Hcv ns5b gt1b n316y with cmpd 32 |
|
199
|
563
|
4ke5A |
Hcv ns5b gt1b n316y with gsk5852 |
|
200
|
563
|
4jjuA |
Crystal structure of hcv ns5b polymerase in complex with compound 29 |
|
200
|
563
|
4ju1A |
Crystal structure of hcv ns5b polymerase in complex with compound 6 |
|
197
|
563
|
4jy1A |
Crystal structure of hcv ns5b polymerase in complex with compound 5 |
|
201
|
564
|
4kaiA |
Hcv ns5b gt1b n316 with gsk5852a |
|
205
|
563
|
4ju3A |
Crystal structure of hcv ns5b polymerase in complex with compound 8 |
|
178
|
595
|
4kh5A |
Toxoplasma gondii ntpdase1 c258s/c268s in complex with mg and ampnp |
|
202
|
563
|
4jjsA |
Crystal structure of hcv ns5b polymerase in complex with compound 2 |
|
203
|
563
|
4ju4A |
Crystal structure of hcv ns5b polymerase in complex with compound 22 |
|
18
|
222
|
4l3bA |
X-ray structure of the hrv2 a particle uncoating intermediate |
|
201
|
563
|
4jtyA |
Crystal structure of hcv ns5b polymerase with compound 2 |
|
200
|
563
|
4jtwA |
Crystal structure of hcv ns5b polymerase in complex with coupound 1 |
|
16
|
248
|
4l3bB |
X-ray structure of the hrv2 a particle uncoating intermediate |
|
201
|
563
|
4ju6A |
Crystal structure of hcv ns5b polymerase in complex with compound 24 |
|
197
|
596
|
4kh6A |
Toxoplasma gondii ntpdase1 c258s/c268s e493g crystallized with mg and ampnp |
|
199
|
563
|
4kbiA |
Hcv ns5b gt1b n316y with cmpd 4 |
|
195
|
563
|
4jtzA |
Crystal structure of hcv ns5b polymerase in complex with compound 4 |
|
14
|
237
|
4l3bC |
X-ray structure of the hrv2 a particle uncoating intermediate |
|
202
|
563
|
4ju2A |
Crystal structure of hcv ns5b polymerase in complex with compound 12 |
|
201
|
563
|
4jvqA |
Crystal structure of hcv ns5b polymerase in complex with compound 9 |
|
184
|
595
|
4kh4A |
Toxoplasma gondii ntpdase1 c258s/c268s in complex with mg and amppnp |
|
201
|
563
|
4ju7A |
Crystal structure of hcv ns5b polymerase in complex with compound 24 |
|
40
|
175
|
4ktcA |
Ns3/ns4a protease with inhibitor |
|
46
|
182
|
4i33A |
Crystal structure of hcv ns3/4a r155k protease complexed with compound 4 |
|
207
|
563
|
4j08A |
Crystal structure of hcv ns5b polymerase in complex with 2-{[(4-methylphenyl)sulfonyl]amino}-5-phenoxybenzoic acid |
|
205
|
562
|
4ih7A |
Hepatitis c virus polymerase ns5b (bk) with fragment-based compounds |
|
206
|
562
|
4ih6A |
Hepatitis c virus polymerase ns5b (bk) with fragment-based compounds |
|
37
|
182
|
4in1A |
Structural basis of substrate specificity and protease inhibition in norwalk virus |
